These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3030978)

  • 1. An overview of angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):175-80. PubMed ID: 3030978
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of angiotensin-converting enzyme inhibitors.
    Wyvratt MJ
    Clin Physiol Biochem; 1988; 6(3-4):217-29. PubMed ID: 2849521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of enalapril in moderate to severe essential hypertension.
    Walker JF; Kulaga SF; Kramsch DM
    J Hypertens Suppl; 1984 Dec; 2(2):S107-11. PubMed ID: 6100871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of two angiotensin converting enzyme inhibitors in primary hypertension--a comparison of captopril and enalapril.
    Karlberg BE; Sjöstrand A; Ohman KP
    J Hypertens Suppl; 1986 Dec; 4(5):S432-4. PubMed ID: 3033182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors: are they all alike?
    Case DB
    J Clin Hypertens; 1987 Sep; 3(3):243-56. PubMed ID: 2822859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of action and clinical use of converting enzyme inhibitors].
    Lazowski J; Rewerski W
    Pol Tyg Lek; 1986 Dec; 41(48):1507-11. PubMed ID: 3035518
    [No Abstract]   [Full Text] [Related]  

  • 8. [Converting enzyme inhibitors in the treatment of essential hypertension].
    Sancho Rof J
    Med Clin (Barc); 1985 Nov; 85(14):578-80. PubMed ID: 3001445
    [No Abstract]   [Full Text] [Related]  

  • 9. Tailoring antihypertensive treatment: which patients, what therapy?
    Neal W
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):190-3. PubMed ID: 3030980
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
    Modesti PA; Vanni S; Gensini GF
    Ital Heart J Suppl; 2003 Aug; 4(8):623-34. PubMed ID: 14655458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of angiotensin converting enzyme as a therapeutic approach: the pros and cons].
    Waeber B; Waeber G; Nussberger J; Brunner HR
    Rev Med Brux; 1986 Apr; 7(4):227-30. PubMed ID: 3014629
    [No Abstract]   [Full Text] [Related]  

  • 13. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE-inhibitors in the treatment of elderly hypertensives.
    M'Buyamba-Kabangu JR; Fagard R; Lijnen P; Staessen J; Van Hoof R; Amery A
    Geriatrics; 1987 Jun; 42(6):45-9. PubMed ID: 3034739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitors of angiotensin-converting enzyme in cardiac insufficiency].
    Amodeo C
    Arq Bras Cardiol; 1990 Feb; 54(2):97-9. PubMed ID: 2175595
    [No Abstract]   [Full Text] [Related]  

  • 17. Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
    Ferguson RK; Vlasses PH; Riley LJ
    Ration Drug Ther; 1984 Mar; 18(3):1-5. PubMed ID: 6093192
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience with a new antihypertensive drug (captopril SQ 14.225), an oral inhibitor of converting enzyme].
    Santucci A; Aguglia F; Ficara C
    Clin Ter; 1981 Apr; 97(1):43-58. PubMed ID: 6269793
    [No Abstract]   [Full Text] [Related]  

  • 19. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of enalapril. Summing up the evidence.
    Dollery CT
    J Hypertens Suppl; 1983 Oct; 1(1):155-7. PubMed ID: 6100605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.